Read more
9:29 PM ยท 17 November 2025

Soybean at 15-month high on USDA report and US-China trade optimism ๐Ÿ“ˆ ๐Ÿซ›

Key takeaways
SOYBEAN
Commodities
-
-
Key takeaways
  • Soybean contract breaks above key resistance on renewed demand expectation
  • Additionally, the latest USDA report forecasts lower production, suggesting a price-inducing market squize.

Soybean futures rose sharply today (+2.4%), recovering from recent declines as traders reacted to renewed optimism over the U.S.–China agricultural trade. January CBOT soybeans gained 20½ cents to $11.45 per bushel, supported by expectations that China may step up purchases of U.S. soybeans following recent diplomatic discussions. 

Erratic rainfall in Brazil also bolstered prices by raising concerns over supply. Soymeal and soyoil followed mixed patterns, while corn futures saw modest gains, reflecting broader grain market support in the aftermath of the most recent USDA report. The institution forecasts U.S. soybean production at 4.25 billion bushels, slightly lower than expected and down 3 percent from last year. Yields are projected to reach a record 53 bushels per acre, while the total area harvested is smaller than 2024 at 80.3 million acres.

 

The contract SOYBEAN rebounded sharply from early trading sellout, driving the price up to its 15-month high. The RSI is currently entering the overbought area, though changing supply and demand fundamentals will likely sustain the higher valuation. Source: xStation5

18 November 2025, 12:44 PM

AI Battle: Huawei vs Nvidia

18 November 2025, 10:44 AM

Morning Wrap (18.11.2025)

17 November 2025, 10:58 PM

Daily summary: Risk assets keep sliding on US rate cut jitters (17.11.2025)

17 November 2025, 7:47 PM

Quantum Computing after Earnings: Quantum Breakthough?

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 2 000 000 investors from around the world